When deciding which stocks to invest in, understanding which exchanges they are listed on can make a big difference in long-term performance and perception. For most U.S.
-based investors, the two exchanges they hear about the most are the New York Stock Exchange (NYSE) and the Nasdaq . The NYSE is known for its relative stability and historically blue-chip stocks . On the other hand, the Nasdaq is a staple of high-growth and more speculative ventures like information technology, biotechnology and market disruptors.
Yet, due to this reputation, Nasdaq stocks tend to be more volatile over short periods, leading to some Nasdaq stocks to sell. In the case of these three companies, both broader market pressures and institutional overvaluations have put them in positions worth selling from. Furthermore, these companies may be at the end of their speculative roads, leading investors to want more growth where there may not be any left.
BioNTech (BNTX) A product of the COVID-19 pandemic, BioNTech (NASDAQ: BNTX ) has been steadily losing value ever since its meteoric spike from developing a vaccine alongside Pfizer (NYSE: PFE ). The best time to have sold would have been back in 2021 to take advantage of its extreme overvaluation at the time. Today, the company focuses on utilizing the mRNA drug delivery platform to treat cancer and has several such fully-owned drugs in the pipeline for diseases like melanoma and head and neck cancer.
The company also deeply invests in its collaborativ.